Clinical evaluation of NA872 in the treatment of chronic paranasal sinusitis. A double blind trial comparing NA872 with Mecysteine hydrochloride.

@article{Ohyama1989ClinicalEO,
  title={Clinical evaluation of NA872 in the treatment of chronic paranasal sinusitis. A double blind trial comparing NA872 with Mecysteine hydrochloride.},
  author={M. Ohyama and S. Furuta and K. Fukami},
  journal={Practica oto-rhino-laryngologica},
  year={1989},
  volume={82},
  pages={1649-1665}
}
In an evaluation of the clinical usefulness of ambroxol hydrochloride (NA872) in the treatment of chronic paranasal sinusitis, a double blind trial was carried out comparing NA872 with Mecysteine hydrochloride (Mecysteine). The NA872 treated patients (N-Group) were given one tablet of NA872 (15 mg) and one placebo tablet orally after each meal, and the Mecysteine treated patients (M-Group) were given one tablet of Mecysteine (100 mg) and one placebo tablet orally after each meal for four weeks… Expand